Skip to content
Home/Companies/Biotech/Fusion Pharmaceuticals Inc.

Fusion Pharmaceuticals Inc.

Biotech·Canada·Exited 2024·Held 7yr
Entry
2017
Hold
7yr
Exit
2024

Who owns Fusion Pharmaceuticals Inc.?

Fusion Pharmaceuticals Inc. is a Canadian Biotech company, now owned by AstraZeneca, which acquired it in 2024 from HealthCap.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap VII · 2016 · VC

Key facts

HQCanada
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
AstraZeneca
Exit Year
2024

More from HealthCap VII

Other portfolio companies in the same fund.

Mahzi Therapeutics
Active
BiotechUS· 2020
Priothera Ltd.
Active
BiotechIreland· 2020
SynOx Therapeutics Ltd
Active
BiotechIreland· 2020
Carisma Therapeutics
Exited 2023
BiotechUS· 2018
to Sesen Bio, Inc.
InCarda Therapeutics Inc.
Active
BiotechUS· 2018
Modus Therapeutics
Modus Therapeutics
Active
BiotechSweden· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Fusion Pharmaceuticals Inc.?

Fusion Pharmaceuticals Inc. is now owned by AstraZeneca, which acquired it in 2024 from HealthCap.

When did AstraZeneca acquire Fusion Pharmaceuticals Inc.?

AstraZeneca acquired Fusion Pharmaceuticals Inc. in 2024, buying from HealthCap.

Who did Fusion Pharmaceuticals Inc. sell to?

HealthCap sold Fusion Pharmaceuticals Inc. to AstraZeneca in 2024 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue